Lee Biosolutions

Human Anti centriole and centrosome antibody IgG ELISA kit
E01A0698-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human IgG antibody Laboratories manufactures the lee biosolutions reagents distributed by Genprice. The Lee Biosolutions reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other Lee products are available in stock. Specificity: Lee Category: Biosolutions

True north Cryobox 15mLBlue
PK10
EUR 212.4

True north Cryobox 50mLNatural
PK10
EUR 210

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

Human true insulin,TI ELISA Kit
96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human true insulin,TI ELISA Kit
96T
EUR 567.6

Chemicals information

LEE011
A8641-10 10 mg
EUR 226.8
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-25 25 mg
EUR 338.4
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-5 5 mg
EUR 170.4
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-5.1 10 mM (in 1mL DMSO)
EUR 181.2
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-50 50 mg
EUR 408
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
GW0606-1 1
EUR 121.8

LEE011
GW0606-10 10
EUR 237.4

LEE011
GW0606-5 5
EUR 171.5

LEE011 succinate
B1084-10 10 mg
EUR 200.4
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-100 100 mg
EUR 420
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-200 200 mg
EUR 640.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5 5 mg
EUR 160.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5.1 10 mM (in 1mL DMSO)
EUR 192
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-50 50 mg
EUR 300
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-500 500 mg
EUR 1101.6
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-25 25mg
EUR 200
Description: CDK inhibitor

Ribociclib (LEE011)
9481-25 each
EUR 548.4